Camp4 Therapeutics Poration Stock Debt To Equity

CAMP Stock

USD 4.79 0.10 2.13%

CAMP4 THERAPEUTICS PORATION fundamentals help investors to digest information that contributes to CAMP4 THERAPEUTICS's financial success or failures. It also enables traders to predict the movement of CAMP4 Stock. The fundamental analysis module provides a way to measure CAMP4 THERAPEUTICS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CAMP4 THERAPEUTICS stock.

		Last Reported	Projected for Next Year
	Debt To Equity	1.70	0.89

As of 11/29/2024, Debt To Equity is likely to drop to 0.89.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CAMP4 THERAPEUTICS PORATION Company Debt To Equity Analysis

CAMP4 THERAPEUTICS's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

Current CAMP4 THERAPEUTICS Debt To Equity

0.89

Most of CAMP4 THERAPEUTICS's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CAMP4 THERAPEUTICS PORATION is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

CAMP4 Debt To Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for CAMP4 THERAPEUTICS is extremely important. It helps to project a fair market value of CAMP4 Stock properly, considering its historical fundamentals such as Debt To Equity. Since CAMP4 THERAPEUTICS's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CAMP4 THERAPEUTICS's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CAMP4 THERAPEUTICS's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Invested Capital	Capital Stock	Net Working Capital
Total Assets		0.99	0.89	-0.73	0.77	0.72	-0.62	0.94	0.94	1.0	0.77	0.85	-0.95	0.96	0.91	0.95
Total Stockholder Equity	0.99		0.93	-0.79	0.83	0.61	-0.66	0.95	0.9	0.99	0.82	0.91	-0.96	0.92	0.87	0.92
Current Deferred Revenue	0.89	0.93		-0.78	0.95	0.37	-0.52	0.92	0.78	0.91	0.91	0.98	-0.9	0.74	0.69	0.74
Net Debt	-0.73	-0.79	-0.78		-0.62	-0.31	0.92	-0.62	-0.69	-0.74	-0.59	-0.78	0.87	-0.63	-0.48	-0.72
Retained Earnings	0.77	0.83	0.95	-0.62		0.18	-0.3	0.91	0.65	0.8	0.99	0.97	-0.78	0.59	0.56	0.57
Accounts Payable	0.72	0.61	0.37	-0.31	0.18		-0.43	0.52	0.81	0.69	0.18	0.27	-0.6	0.86	0.81	0.85
Net Receivables	-0.62	-0.66	-0.52	0.92	-0.3	-0.43		-0.42	-0.62	-0.62	-0.28	-0.51	0.75	-0.63	-0.47	-0.72
Good Will	0.94	0.95	0.92	-0.62	0.91	0.52	-0.42		0.83	0.95	0.91	0.92	-0.88	0.85	0.84	0.81
Total Liab	0.94	0.9	0.78	-0.69	0.65	0.81	-0.62	0.83		0.93	0.66	0.75	-0.94	0.92	0.8	0.97
Total Current Assets	1.0	0.99	0.91	-0.74	0.8	0.69	-0.62	0.95	0.93		0.79	0.87	-0.95	0.95	0.9	0.94
Short Term Debt	0.77	0.82	0.91	-0.59	0.99	0.18	-0.28	0.91	0.66	0.79		0.96	-0.78	0.58	0.55	0.58
Intangible Assets	0.85	0.91	0.98	-0.78	0.97	0.27	-0.51	0.92	0.75	0.87	0.96		-0.9	0.68	0.62	0.7
Common Stock	-0.95	-0.96	-0.9	0.87	-0.78	-0.6	0.75	-0.88	-0.94	-0.95	-0.78	-0.9		-0.87	-0.75	-0.93
Net Invested Capital	0.96	0.92	0.74	-0.63	0.59	0.86	-0.63	0.85	0.92	0.95	0.58	0.68	-0.87		0.96	0.98
Capital Stock	0.91	0.87	0.69	-0.48	0.56	0.81	-0.47	0.84	0.8	0.9	0.55	0.62	-0.75	0.96		0.88
Net Working Capital	0.95	0.92	0.74	-0.72	0.57	0.85	-0.72	0.81	0.97	0.94	0.58	0.7	-0.93	0.98	0.88

Click cells to compare fundamentals

CAMP4 Debt To Equity Historical Pattern

Today, most investors in CAMP4 THERAPEUTICS Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CAMP4 THERAPEUTICS's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's debt to equity growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CAMP4 THERAPEUTICS debt to equity as a starting point in their analysis.

CAMP4 THERAPEUTICS Debt To Equity

Timeline

High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

Competition

Predict CAMP4 THERAPEUTICS

Debt To Equity Over Time

CAMP4 Total Stockholder Equity

Total Stockholder Equity

(117.54 Million)

CAMP4 THERAPEUTICS reported last year Total Stockholder Equity of (123.73 Million)

CAMP4 Debt To Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CAMP4 THERAPEUTICS's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CAMP4 THERAPEUTICS could also be used in its relative valuation, which is a method of valuing CAMP4 THERAPEUTICS by comparing valuation metrics of similar companies.

CAMP4 THERAPEUTICS is currently under evaluation in debt to equity category among its peers.

CAMP4 THERAPEUTICS ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CAMP4 THERAPEUTICS's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CAMP4 THERAPEUTICS's managers, analysts, and investors.

Environmental

Governance

Social

CAMP4 Fundamentals

	Price To Earning	318.57 X
	Revenue	186.23 M
	EBITDA	(8.72 M)
	Net Income	(49.29 M)
	Cash And Equivalents	47.72 M
	Cash Per Share	1.29 X
	Total Debt	178.68 M
	Current Ratio	1.86 X
	Book Value Per Share	(45.01) X
	Cash Flow From Operations	(44.16 M)
	Earnings Per Share	(63.02) X
	Price To Earnings To Growth	0.08 X
	Target Price	14.18
	Number Of Employees	58
	Beta	1.89
	Market Capitalization	660.34 K
	Total Asset	54.95 M
	Retained Earnings	(159.96 M)
	Working Capital	32.21 M
	Current Asset	298.77 M
	Current Liabilities	49.56 M
	Net Asset	54.95 M

About CAMP4 THERAPEUTICS Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CAMP4 THERAPEUTICS PORATION's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CAMP4 THERAPEUTICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CAMP4 THERAPEUTICS PORATION based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with CAMP4 THERAPEUTICS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.

Moving against CAMP4 Stock

0.67	VINC	Vincerx Pharma	Pair Corr
0.42	DTIL	Precision BioSciences	Pair Corr
0.32	DRMA	Dermata Therapeutics	Pair Corr
0.31	VCNX	Vaccinex	Pair Corr
0.31	DRTS	Alpha Tau Medical	Pair Corr

The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.

The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC